Retinal Vein Occlusion and Inherited Conditions Predisposing to Thrombophilia

Rosina Albisinni; Antonio Coppola; Marcello Loffredo; Anna Maria Cerbone; Giovanni Di Minno; Giovanni Maria Greco

doi:10.1055/s-0037-1615445

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 1998; 80(04): 702-703
DOI: 10.1055/s-0037-1615445

Letters to the Editor

Schattauer GmbH

Retinal Vein Occlusion and Inherited Conditions Predisposing to Thrombophilia

Autoren

Rosina Albisinni

¹From the Departments of Clinical and Experimental Medicine, Naples, Italy
Antonio Coppola

¹From the Departments of Clinical and Experimental Medicine, Naples, Italy
Marcello Loffredo

¹Opthalmology, University of Naples “Federico II”, Naples, Italy
Anna Maria Cerbone

¹From the Departments of Clinical and Experimental Medicine, Naples, Italy
Giovanni Di Minno

¹From the Departments of Clinical and Experimental Medicine, Naples, Italy
Giovanni Maria Greco

¹Opthalmology, University of Naples “Federico II”, Naples, Italy

Abstract

Volltext

Referenzen

References
1 Appiah AP, Trempe CL. Risk factors associated with branch vs. central retinal vein occlusion. Ann Ophtalmol 1989; 21: 153-7.
2 Dodson PM, Kubicki AS, Taylor KG, Kritzinger EE. Medical conditions underlying recurrence of retinal vein occlusion. Br J Ophtalmol 1985; 69: 493-6.
3 Arend O, Renky A, Jung F, Kiesewetter H, Reim M, Wolf S. Role of rheologic factors in patients with acute central retinal vein occlusion. Ophtalmology 1996; 103: 80-6.
4 Williamson TH, Rumley A, Lowe GDO. Blood viscosity, coagulation and activated protein C resistance in central retinal vein occlusion: a population controlled study. Br J Ophtalmol 1996; 80: 203-8.
5 Bandello F, Viganò D’Angelo S, Parlavecchia M, Tavola A, Della Valle P, Brancato R, D’Angelo A. Hypercoagulability and high lipoprotein (a) levels in patients with central retinal vein occlusion. Thromb Haemost 1994; 72: 39-43.
6 Dahlbäck B. Inherited thrombophilia: resistance to activated protein C as a pathogenic factor of venous thromboembolism. Blood 1995; 85: 607-14.
7 Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Driven RJ, De Ronde H, Van der Velden PA, Reitsma PH. Mutation in blood coagulation factor V associated with resistence to activated protein C. Nature 1994; 369: 64-7.
8 Poort SW, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3’-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and in increase in venous thombosis. Blood 1996; 88: 3698-703.
9 Hillarp A, Zöller B, Svensson PJ, Dahlbäck B. The 20210A allele of the prothrombin gene is a common risk factor among Swedish outpatients with verified deep venous thrombosis. Thromb Haemost 1997; 78: 990-2.